Claire Bastian1, Jean-Baptiste Muller1, Stephen Lortat-Jacob2, Claire Nihoul-Fékété3, Joelle Bignon-Topalovic4, Ken McElreavey5, Anu Bashamboo4, Raja Brauner1. 1. Université Paris Descartes and Pediatric Endocrinology Unit, Fondation Ophtalmologique Adolphe de Rothschild, Paris, France. 2. Assistance Publique-Hôpitaux de Paris, Hôpital Necker-Enfants Malades, Service de chirurgie viscérale pédiatrique, Paris, France. 3. Université Paris Descartes, Institut Pasteur, Paris, France. 4. Human Developmental Genetics, Institut Pasteur, Paris, France. 5. Human Developmental Genetics, Institut Pasteur, Paris, France. Electronic address: kenneth.mcelreavey@pasteur.fr.
Abstract
OBJECTIVE: To assess genetic mutations and associated somatic anomalies in a series of patients with 46,XY gonadal dysgenesis (GD). DESIGN: Single center retrospective study. SETTING: University pediatric hospital. PATIENT(S): Fourteen patients with 46,XY GD. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Genotype-phenotype relationship. RESULT(S): The presenting symptom was disorders of sex development (6 patients), primary amenorrhea (2 patients), discordance between 46,XY karyotype and female external genitalia (3 patients), discovery of Müllerian structures at surgery (2 patients), or diagnosed in the evaluation of a gonadal tumor (1 patient). Müllerian structures were shown by ultrasound evaluation in 7 of 13 patients, genitography in 3 of 6 patients and/or surgery in 8 of 10 patients (3 not seen at imaging), or only by histologic examination (1 patient). Three patients had gonadoblastoma and/or seminoma. A mutation was found in 7 patients of whom 2 had family history of reproductive problems and 5 had associated somatic anomalies. The mutations were FOG2/ZFPM2 (1 patient), SRY (2 patients), WT1 (1 patient), or deletions of distal chromosome 9p (3 patients). Among the three other patients with associated anomalies and no mutation, two had ectodermal dysplasia and one had leukemia. CONCLUSION(S): Mutations were observed in half of the patients with 46,XY GD with Müllerian structures. We also describe for the first time the association between GD and ectodermal dysplasia. Müllerian structures can be found in some cases only by histologic examination, which should be coupled to preventive gonadectomy because of the risk of tumor formation.
OBJECTIVE: To assess genetic mutations and associated somatic anomalies in a series of patients with 46,XY gonadal dysgenesis (GD). DESIGN: Single center retrospective study. SETTING: University pediatric hospital. PATIENT(S): Fourteen patients with 46,XY GD. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Genotype-phenotype relationship. RESULT(S): The presenting symptom was disorders of sex development (6 patients), primary amenorrhea (2 patients), discordance between 46,XY karyotype and female external genitalia (3 patients), discovery of Müllerian structures at surgery (2 patients), or diagnosed in the evaluation of a gonadal tumor (1 patient). Müllerian structures were shown by ultrasound evaluation in 7 of 13 patients, genitography in 3 of 6 patients and/or surgery in 8 of 10 patients (3 not seen at imaging), or only by histologic examination (1 patient). Three patients had gonadoblastoma and/or seminoma. A mutation was found in 7 patients of whom 2 had family history of reproductive problems and 5 had associated somatic anomalies. The mutations were FOG2/ZFPM2 (1 patient), SRY (2 patients), WT1 (1 patient), or deletions of distal chromosome 9p (3 patients). Among the three other patients with associated anomalies and no mutation, two had ectodermal dysplasia and one had leukemia. CONCLUSION(S): Mutations were observed in half of the patients with 46,XY GD with Müllerian structures. We also describe for the first time the association between GD and ectodermal dysplasia. Müllerian structures can be found in some cases only by histologic examination, which should be coupled to preventive gonadectomy because of the risk of tumor formation.
Authors: Dara Tolchin; Jessica P Yeager; Priya Prasad; Naghmeh Dorrani; Alvaro Serrano Russi; Julian A Martinez-Agosto; Abdul Haseeb; Marco Angelozzi; G W E Santen; Claudia Ruivenkamp; Saadet Mercimek-Andrews; Christel Depienne; Alma Kuechler; Barbara Mikat; Hermann-Josef Ludecke; Frederic Bilan; Gwenael Le Guyader; Brigitte Gilbert-Dussardier; Boris Keren; Solveig Heide; Damien Haye; Hilde Van Esch; Liesbeth Keldermans; Damara Ortiz; Emily Lancaster; Ian D Krantz; Bryan L Krock; Kieran B Pechter; Alexandre Arkader; Livija Medne; Elizabeth T DeChene; Eduardo Calpena; Giada Melistaccio; Andrew O M Wilkie; Mohnish Suri; Nicola Foulds; Amber Begtrup; Lindsay B Henderson; Cara Forster; Patrick Reed; Marie T McDonald; Allyn McConkie-Rosell; Julien Thevenon; Pauline Le Tanno; Charles Coutton; Anne C H Tsai; Sarah Stewart; Ales Maver; Rudolf Gorazd; Olivier Pichon; Mathilde Nizon; Benjamin Cogné; Bertrand Isidor; Dominique Martin-Coignard; Radka Stoeva; Véronique Lefebvre; Cédric Le Caignec Journal: Am J Hum Genet Date: 2020-05-21 Impact factor: 11.025